Lobeline

Lobeline
Systematic (IUPAC) name
2-((2R,6S)-6-((S)-2-Hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethanone
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
CAS Number 90-69-7 N
ATCvet code QV04CV01(WHO)
PubChem CID 101616
ChemSpider 91814 N
UNII D0P25S3P81 YesY
KEGG D02364 YesY
ChEMBL CHEMBL2103769 YesY
Chemical data
Formula C22H27NO2
Molar mass 337.455
 NYesY (what is this?)  (verify)

Lobeline is an alkaloid found in "Indian tobacco" (Lobelia inflata), "Devil's tobacco" (Lobelia tupa), "cardinal flower" (Lobelia cardinalis), "great lobelia" (Lobelia siphilitica), and Hippobroma longiflora. Additionally, it is also found in Lobelia chinensis. In its pure form it is a white amorphous powder which is freely soluble in water.

Potential uses

Lobeline has been sold, in tablet form, for use as a smoking cessation aid,[1][2][3] and may have application in the treatment of other drug addictions such as addiction to amphetamines,[4][5] cocaine,[6] or alcohol.[7]

Pharmacology

Lobeline has multiple mechanisms of action, acting as a VMAT2 ligand,[8][9][10] which stimulates dopamine release to a moderate extent when administered alone, but reduces the dopamine release caused by methamphetamine.[11][12] It also inhibits the reuptake of dopamine and serotonin,[13] and acts as a mixed agonist–antagonist at nicotinic acetylcholine receptors[14][15] to which it binds at the subunit interfaces of the extracellular domain.[16] It is also an antagonist at μ-opioid receptors.[17]

References

  1. ↑ Stead LF, Hughes JR; Hughes (2012). "Lobeline for smoking cessation". Cochrane Database Syst Rev 2: CD000124. doi:10.1002/14651858.CD000124.pub2. PMID 22336780.
  2. ↑ Marlow, S. P.; Stoller, J. K. (2003). "Smoking cessation". Respiratory care 48 (12): 1238–54; discussion 1254–6. PMID 14651764.
  3. ↑ Buchhalter, A. R.; Fant, R. V.; Henningfield, J. E. (2008). "Novel pharmacological approaches for treating tobacco dependence and withdrawal: Current status". Drugs 68 (8): 1067–88. doi:10.2165/00003495-200868080-00005. PMID 18484799.
  4. ↑ Neugebauer, N. M.; Harrod, S. B.; Stairs, D. J.; Crooks, P. A.; Dwoskin, L. P.; Bardo, M. T. (2007). "Lobelane decreases methamphetamine self-administration in rats". European Journal of Pharmacology 571 (1): 33–8. doi:10.1016/j.ejphar.2007.06.003. PMC 2104779. PMID 17612524.
  5. ↑ Eyerman, D. J.; Yamamoto, B. K. (2005). "Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum". Journal of Pharmacology and Experimental Therapeutics 312 (1): 160–9. doi:10.1124/jpet.104.072264. PMID 15331654.
  6. ↑ Polston, J. E.; Cunningham, C. S.; Rodvelt, K. R.; Miller, D. K. (2006). "Lobeline augments and inhibits cocaine-induced hyperactivity in rats". Life Sciences 79 (10): 981–90. doi:10.1016/j.lfs.2006.05.006. PMID 16765386.
  7. ↑ Farook, J. M.; Lewis, B; Gaddis, J. G.; Littleton, J. M.; Barron, S (2009). "Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice". Physiology & Behavior 97 (3–4): 503–6. doi:10.1016/j.physbeh.2009.02.031. PMID 19268674.
  8. ↑ Zheng, G; Dwoskin, L. P.; Crooks, P. A. (2006). "Vesicular monoamine transporter 2: Role as a novel target for drug development". The AAPS Journal 8 (4): E682–92. doi:10.1208/aapsj080478. PMC 2751365. PMID 17233532.
  9. ↑ Zheng, F; Zheng, G; Deaciuc, A. G.; Zhan, C. G.; Dwoskin, L. P.; Crooks, P. A. (2007). "Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2". Bioorganic & Medicinal Chemistry 15 (8): 2975–92. doi:10.1016/j.bmc.2007.02.013. PMC 2001191. PMID 17331733.
  10. ↑ Zheng, G; Dwoskin, L. P.; Deaciuc, A. G.; Norrholm, S. D.; Crooks, P. A. (2005). "Defunctionalized lobeline analogues: Structure-activity of novel ligands for the vesicular monoamine transporter". Journal of Medicinal Chemistry 48 (17): 5551–60. doi:10.1021/jm0501228. PMC 3617589. PMID 16107155.
  11. ↑ Wilhelm, C. J.; Johnson, R. A.; Eshleman, A. J.; Janowsky, A (2008). "Lobeline effects on tonic and methamphetamine-induced dopamine release". Biochemical Pharmacology 75 (6): 1411–5. doi:10.1016/j.bcp.2007.11.019. PMC 2435375. PMID 18191815.
  12. ↑ Wilhelm, C. J.; Johnson, R. A.; Lysko, P. G.; Eshleman, A. J.; Janowsky, A (2004). "Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system". Journal of Pharmacology and Experimental Therapeutics 310 (3): 1142–51. doi:10.1124/jpet.104.067314. PMID 15102929.
  13. ↑ Zheng, G; Horton, D. B.; Deaciuc, A. G.; Dwoskin, L. P.; Crooks, P. A. (2006). "Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters". Bioorganic & Medicinal Chemistry Letters 16 (19): 5018–21. doi:10.1016/j.bmcl.2006.07.070. PMC 3934794. PMID 16905316.
  14. ↑ Damaj, M. I.; Patrick, G. S.; Creasy, K. R.; Martin, B. R. (1997). "Pharmacology of lobeline, a nicotinic receptor ligand". The Journal of Pharmacology and Experimental Therapeutics 282 (1): 410–9. PMID 9223582.
  15. ↑ Miller, D. K.; Harrod, S. B.; Green, T. A.; Wong, M. Y.; Bardo, M. T.; Dwoskin, L. P. (2003). "Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats". Pharmacology, Biochemistry, and Behavior 74 (2): 279–86. doi:10.1016/s0091-3057(02)00996-6. PMID 12479946.
  16. ↑ PDB entry 2bys. Hansen, S. B.; Sulzenbacher, G; Huxford, T; Marchot, P; Taylor, P; Bourne, Y (2005). "Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations". The EMBO Journal 24 (20): 3635–46. doi:10.1038/sj.emboj.7600828. PMC 1276711. PMID 16193063.
  17. ↑ Miller, D. K.; Lever, J. R.; Rodvelt, K. R.; Baskett, J. A.; Will, M. J.; Kracke, G. R. (2007). "Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists". Drug and Alcohol Dependence 89 (2–3): 282–91. doi:10.1016/j.drugalcdep.2007.02.003. PMID 17368966.

This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.